Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 642793, 12 pages
http://dx.doi.org/10.1155/2014/642793
Research Article

High-Dialysate-Glucose-Induced Oxidative Stress and Mitochondrial-Mediated Apoptosis in Human Peritoneal Mesothelial Cells

1Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 106, Taiwan
2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan
3Division of Nephrology, Department of Internal Medicine, Kuan-Tien General Hospital, Taichung 433, Taiwan
4Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110, Taiwan

Received 29 January 2014; Revised 30 March 2014; Accepted 1 April 2014; Published 5 May 2014

Academic Editor: Lubomir Prochazka

Copyright © 2014 Kuan-Yu Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. García-López, B. Lindholm, and S. Davies, “An update on peritoneal dialysis solutions,” Nature Reviews Nephrology, vol. 8, no. 4, pp. 224–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. S. A. Fenton, D. E. Schaubel, M. Desmeules et al., “Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates,” American Journal of Kidney Diseases, vol. 30, no. 3, pp. 334–342, 1997. View at Google Scholar · View at Scopus
  3. J. D. Williams, K. J. Craig, C. von Ruhland, N. Topley, and G. T. Williams, “The natural course of peritoneal membrane biology during peritoneal dialysis,” Kidney International, vol. 64, no. 88, pp. S43–S49, 2003. View at Google Scholar · View at Scopus
  4. C. Higuchi, H. Nishimura, and T. Sanaka, “Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis,” Therapeutic Apheresis and Dialysis, vol. 10, no. 4, pp. 372–379, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Williams, K. J. Craig, N. Topley et al., “Morphologic changes in the peritoneal membrane of patients with renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 2, pp. 470–479, 2002. View at Google Scholar · View at Scopus
  6. K. Ksi̧zek, K. Korybalska, A. Jörres, and J. Witowski, “Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-β1,” Laboratory Investigation, vol. 87, no. 4, pp. 345–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Boulanger, M.-P. Wautier, P. Gane, C. Mariette, O. Devuyst, and J.-L. Wautier, “The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products,” Nephrology Dialysis Transplantation, vol. 19, no. 9, pp. 2208–2216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Mishra, S. N. Emancipator, T. Kern, and M. S. Simonson, “High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells,” Kidney International, vol. 67, no. 1, pp. 82–93, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K.-Y. Hung, J.-W. Huang, C.-K. Chiang, and T.-J. Tsai, “Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies,” Nephrology Dialysis Transplantation, vol. 23, no. 12, pp. 3831–3840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Wang, “The expanding role of mitochondria in apoptosis,” Genes and Development, vol. 15, no. 22, pp. 2922–2933, 2001. View at Google Scholar · View at Scopus
  11. M. J. Parsons and D. R. Green, “Mitochondria in cell death,” Essays in Biochemistry, vol. 47, pp. 99–114, 2010. View at Google Scholar · View at Scopus
  12. S. Raha and B. H. Robinson, “Mitochondria, oxygen free radicals, and apoptosis,” American Journal of Medical Genetics, vol. 106, no. 1, pp. 62–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Green, M. D. Brand, and M. P. Murphy, “Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes,” Diabetes, vol. 53, no. 1, pp. S110–S118, 2004. View at Google Scholar · View at Scopus
  14. B. P. S. Kang, S. Frencher, V. Reddy, A. Kessler, A. Malhorta, and L. G. Meggs, “High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism,” American Journal of Physiology. Renal Physiology, vol. 284, no. 3, pp. F455–F466, 2003. View at Google Scholar · View at Scopus
  15. D. D'Amours, F. R. Sallmann, V. M. Dixit, and G. G. Poirier, “Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis,” Journal of Cell Science, vol. 114, no. 20, pp. 3771–3778, 2001. View at Google Scholar · View at Scopus
  16. G. Al-Kafaji and J. Golbahar, “High glucose-induced oxidative stress increases the copy number of mitochondrial DNA in human mesangial cells,” BioMed Research International, vol. 2013, Article ID 754946, 8 pages, 2013. View at Publisher · View at Google Scholar
  17. X. Zhu, G. Ling, L. Xiao et al., “Role of mitochondrial respiratory chain complex III in high glucose peritoneal dialysate-induced hyperpermeability of HPMCs,” Renal Failure, vol. 32, no. 9, pp. 1103–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Galloway and Y. Yoon, “Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess,” The Journal of General Physiology, vol. 139, no. 6, pp. 455–463, 2012. View at Google Scholar
  19. Y. Nakabeppu, K. Sakumi, K. Sakamoto, D. Tsuchimoto, T. Tsuzuki, and Y. Nakatsu, “Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids,” Biological Chemistry, vol. 387, no. 4, pp. 373–379, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Suzuki, Y. Hinokio, K. Komatu et al., “Oxidative damage to mitochondrial DNA and its relationship to diabetic complications,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 161–168, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Al-Shabrawey and S. Smith, “Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers,” EPMA Journal, vol. 1, no. 1, pp. 56–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Chen, S. A. Detmer, A. J. Ewald, E. E. Griffin, S. E. Fraser, and D. C. Chan, “Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development,” Journal of Cell Biology, vol. 160, no. 2, pp. 189–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Spinazzi, S. Cazzola, M. Bortolozzi et al., “A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function,” Human Molecular Genetics, vol. 17, no. 21, pp. 3291–3302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Widlansky, J. Wang, S. M. Shenouda et al., “Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes,” Translational Research, vol. 156, no. 1, pp. 15–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Youle and M. Karbowski, “Mitochondrial fission in apoptosis,” Nature Reviews Molecular Cell Biology, vol. 6, no. 8, pp. 657–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Zhu, W. W. Li, and C. Z. Lu, “Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+,” CNS Neuroscience & Therapeutics, vol. 20, no. 4, pp. 308–316.
  27. J. S. Coombes and R. G. Fassett, “Antioxidant therapy in hemodialysis patients: a systematic review,” Kidney International, vol. 81, no. 3, pp. 233–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Himmelfarb, T. A. Ikizler, C. Ellis et al., “Provision of Antioxidant Therapy in Hemodialysis (PATH): a randomized clinical trial,” Journal of the American Society of Nephrology, vol. 25, no. 3, pp. 623–633, 2014. View at Google Scholar
  29. M. Boaz, S. Smetana, T. Weinstein et al., “Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial,” The Lancet, vol. 356, no. 9237, pp. 1213–1218, 2000. View at Google Scholar · View at Scopus
  30. M. Tepel, M. van der Giet, M. Statz, J. Jankowski, and W. Zidek, “The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial,” Circulation, vol. 107, no. 7, pp. 992–995, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Boudouris, I. I. Verginadis, Y. V. Simos et al., “Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation,” International Urology and Nephrology, vol. 45, pp. 1137–1144, 2013. View at Google Scholar